M&T Bank Corp Moderna, Inc. Transaction History

M&T Bank Corp

$139 Billion
Q3 2024

A detailed history of M&T Bank Corp transactions in Moderna, Inc. stock. As of the latest transaction made, M&T Bank Corp holds 16,137 shares of MRNA stock, worth $594,648. This represents 0.0% of its overall portfolio holdings.

Number of Shares

16,137

Previous 20,930 22.9%

Holding current value

$594,648

Previous $2.49 Million 56.62%

% of portfolio

0.0%

Previous 0.01%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 15, 2024	SELL	$63.64 - $125.14 $305,026 - $599,796	-4,793 Reduced 22.9%	16,137 $1.08 Million
Q2 2024 Jul 31, 2024	BUY	$101.21 - $166.61 $501,697 - $825,885	4,957 Added 31.03%	20,930 $2.49 Million
Q1 2024 May 07, 2024	BUY	$85.37 - $115.44 $52,331 - $70,764	613 Added 3.99%	15,973 $1.7 Million
Q4 2023 Feb 06, 2024	SELL	$69.51 - $104.43 $838,221 - $1.26 Million	-12,059 Reduced 43.98%	15,360 $1.53 Million
Q3 2023 Nov 02, 2023	BUY	$96.41 - $126.61 $100,844 - $132,434	1,046 Added 3.97%	27,419 $2.83 Million
Q2 2023 Aug 09, 2023	SELL	$118.5 - $160.53 $167,677 - $227,149	-1,415 Reduced 5.09%	26,373 $3.2 Million
Q1 2023 May 11, 2023	SELL	$135.66 - $197.02 $495,159 - $719,123	-3,650 Reduced 11.61%	27,788 $4.27 Million
Q4 2022 Feb 13, 2023	SELL	$118.38 - $210.04 $3.81 Million - $6.76 Million	-32,176 Reduced 50.58%	31,438 $5.65 Million
Q4 2022 Feb 13, 2023	BUY	$118.38 - $210.04 $3.59 Million - $6.36 Million	30,284 Added 90.86%	63,614 $11.4 Million
Q3 2022 Nov 14, 2022	SELL	$118.07 - $194.18 $40,379 - $66,409	-342 Reduced 1.02%	33,330 $3.82 Million
Q2 2022 Aug 05, 2022	BUY	$117.13 - $176.59 $1.73 Million - $2.61 Million	14,777 Added 78.21%	33,672 $4.61 Million
Q1 2022 May 09, 2022	BUY	$126.46 - $235.05 $447,289 - $831,371	3,537 Added 23.03%	18,895 $3.25 Million
Q4 2021 Feb 07, 2022	BUY	$225.82 - $368.51 $129,394 - $211,156	573 Added 3.88%	15,358 $3.9 Million
Q3 2021 Oct 28, 2021	BUY	$221.9 - $484.47 $165,093 - $360,445	744 Added 5.3%	14,785 $5.69 Million
Q2 2021 Aug 13, 2021	BUY	$129.91 - $234.98 $173,819 - $314,403	1,338 Added 10.53%	14,041 $3.3 Million
Q1 2021 May 06, 2021	SELL	$109.18 - $185.98 $69,547 - $118,469	-637 Reduced 4.78%	12,703 $1.66 Million
Q4 2020 Feb 12, 2021	BUY	$65.74 - $169.86 $57,916 - $149,646	881 Added 7.07%	13,340 $1.39 Million
Q3 2020 Nov 06, 2020	BUY	$54.34 - $94.85 $93,736 - $163,616	1,725 Added 16.07%	12,459 $881,000
Q2 2020 Jul 29, 2020	BUY	$29.67 - $80.0 $109,422 - $295,040	3,688 Added 52.34%	10,734 $688,000
Q1 2020 May 14, 2020	BUY	$17.78 - $31.58 $125,277 - $222,512	7,046 New	7,046 $211,000

Others Institutions Holding MRNA

# of Institutions

954

Shares Held

241M

Call Options Held

10.6M

Put Options Held

18.7M

View Full List

About Moderna, Inc.

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $14.4B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

More about MRNA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of M&T Bank Corp, based on Form 13F filings with the SEC.

News

Stay updated on M&T Bank Corp with notifications on news.

Account